Abstract:In recent years, several important advances have been made in our understanding of the pathways that lead to cell dysfunction and death in Parkinson's disease (PD) and Huntington's disease (HD). Despite distinct clinical and pathological features, these two neurodegenerative diseases share critical processes, such as the presence of misfolded and/or aggregated proteins, oxidative stress, and mitochondrial anomalies. Even though the mitochondria are commonly regarded as the "powerhouses" of the cell, they are involved in a multitude of cellular events such as heme metabolism, calcium homeostasis, and apoptosis. Disruption of mitochondrial homeostasis and subsequent mitochondrial dysfunction play a key role in the pathophysiology of neurodegenerative diseases, further highlighting the importance of these organelles, especially in neurons. The maintenance of mitochondrial integrity through different surveillance mechanisms is thus critical for neuron survival. Mitochondria display a wide range of quality control mechanisms, from the molecular to the organellar level. Interestingly, many of these lines of defense have been found to be altered in neurodegenerative diseases such as PD and HD. Current knowledge and further elucidation of the novel pathways that protect the cell through mitochondrial quality control may offer unique opportunities for disease therapy in situations where ongoing mitochondrial damage occurs. In this review, we discuss the involvement of mitochondrial dysfunction in neurodegeneration with a special focus on the recent findings regarding mitochondrial quality control pathways, beyond the classical effects of increased production of reactive oxygen species (ROS) and bioenergetic alterations. We also discuss how disturbances in these processes underlie the pathophysiology of neurodegenerative disorders such as PD and HD.

Brain Mitochondria, Aging, and Parkinson’s Disease

The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer’s Disease and Parkinson’s Disease

Mitochondrial Dysfunction: A Key Player in Brain Aging and Diseases

New insights into the complex role of mitochondria in Parkinson’s disease

Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection

Understanding the Multiple Role of Mitochondria in Parkinson’s Disease and Related Disorders: Lesson From Genetics and Protein–Interaction Network

Mitochondrial Dynamics in Brain Cells During Normal and Pathological Aging

Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View

Mitochondrial Dysfunction in Parkinson's Disease: From Mechanistic Insights to Therapy

Mitochondria as an easy target to oxidative stress events in Parkinson's disease.

Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease

Mitochondrial Contribution to Parkinson's Disease Pathogenesis

Progress relating to mitochondria dysfunction and Parkinson disease

Significance of Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease

Escalating Bi-Directional Feedback Loops between Proinflammatory Microglia and Mitochondria in Ageing and Post-Diagnosis of Parkinson's Disease

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

Mitostasis in age-associated neurodegeneration

Intracellular and Intercellular Mitochondrial Dynamics in Parkinson's Disease

Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease

Mitochondria-mediated damage to dopaminergic neurons in Parkinson's disease (Review)

Targeting Mitochondrial Dysfunction and Reactive Oxygen Species for Neurodegenerative Disease Treatment